Form 4: Moelis & Co Director Laila Worrell Receives Restricted Stock Units as Dividend Equivalents

Sentiment:

SEC Form 4 Filing


Director Laila Worrell of Moelis & Co received restricted stock units as dividend equivalents on previously issued annual and elective restricted stock units.

Summary

  • Laila Worrell, a director at Moelis & Co, received additional restricted stock units (RSUs) as dividend equivalents.
  • These RSUs are related to previously issued annual and elective RSUs.
  • The dividend equivalent RSUs will vest at the same time as the underlying RSUs.
  • A total of 2,484.43 RSUs were granted related to the 2023 annual RSUs, 1,970.27 RSUs related to the 2024 annual RSUs, and 809.26 RSUs related to the 2024 elective RSUs.
  • The transactions occurred on December 2, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of granting dividend equivalent RSUs, which is a positive sign of aligning director interests with shareholders. There is no negative information.

Positives

  • The grant of dividend equivalent RSUs indicates a continued commitment to aligning director interests with shareholder value.
  • The vesting schedule of the dividend equivalent RSUs is aligned with the underlying RSUs, which simplifies the process.

Industry Context

The granting of restricted stock units as dividend equivalents is a common practice in the financial services industry to align the interests of directors and employees with the long-term performance of the company.

Comparison to Industry Standards

  • Many financial firms use restricted stock units as part of their compensation packages for directors and key employees.
  • The practice of issuing dividend equivalents on RSUs is also common, ensuring that holders receive the same benefits as shareholders during the vesting period.
  • Companies like Goldman Sachs, Morgan Stanley, and JP Morgan Chase also use similar equity compensation methods.

Stakeholder Impact

  • The grant of RSUs to a director aligns their interests with those of shareholders.
  • The vesting of these RSUs will be tied to the performance of the company, which is beneficial for shareholders.

Key Dates

DateDescription
07/03/2023Date of underlying Annual RSUs for the 2023 dividend equivalent RSUs.
07/01/2024Date of underlying Annual and Elective RSUs for the 2024 dividend equivalent RSUs.
12/02/2024Date of the transaction where the dividend equivalent RSUs were granted.
12/04/2024Date the SEC Form 4 was signed.

Keywords

Restricted Stock Units, RSU, Dividend Equivalents, Moelis & Co, Director, Laila Worrell, Equity Compensation, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.